|
Aug 7
|
Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 7
|
Sage tumbles to record low on clinical depression pill setback
|
|
Aug 7
|
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
|
|
Apr 26
|
Earnings Preview: United Therapeutics (UTHR) Q1 Earnings Expected to Decline
|
|
Apr 26
|
Sage Therapeutics, Inc. (NASDAQ:SAGE) insiders placed bullish bets worth US$752k in the last 12 months
|
|
Apr 25
|
Analysts Estimate Sage Therapeutics, Inc. (SAGE) to Report a Decline in Earnings: What to Look Out for
|